Importantly, our IHC studies showed that Ki67+ T cells were not uniformly distributed within tumors and co-localized with areas of viable tumor suggesting a directed homing of tumor-antigen reactive T-cell clones towards target antigen presented on viable RCC tumor cells. The gene discussed is MKI67; the disease is neoplasm.